Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 74951-75000 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05774756
A Trial of Setmelanotide in Acquired Hypothalamic Obesity
PHASE3Active, not recruiting
120 participants
Started: Apr 26, 2023 · Completed: Apr 16, 2027
1 condition1 sponsor28 locations
NCT05832580
The Prevention of Systemic Ectopic Mineralization in Pseudoxanthoma Elasticum
PHASE3Recruiting
76 participants
Started: Apr 26, 2023 · Completed: Apr 29, 2027
1 condition1 sponsor1 location
NCT05854433
Brain Structure and Clinical Endpoints in Myotonic Dystrophy Type 2
N/ARecruiting
100 participants
Started: Apr 26, 2023 · Completed: Jun 30, 2027
2 conditions2 sponsors1 location
NCT04925089
Localized Leiomyosarcoma Biomarker Protocol
N/ARecruiting
40 participants
Started: Apr 26, 2023 · Completed: Sep 30, 2025
1 condition2 sponsors3 locations
NCT05710380
MRI Risk Maps for Prostate Cancer Diagnosis Using Targeted Biopsy
NARecruiting
180 participants
Started: Apr 26, 2023 · Completed: May 1, 2026
3 conditions1 sponsor1 location
NCT05574335
Siplizumab in T1DM
PHASE1/PHASE2Active, not recruiting
120 participants
Started: Apr 26, 2023 · Completed: Oct 30, 2025
1 condition1 sponsor12 locations
NCT05032430
Reducing Maternal Stress to Improve Obesity-related Parenting Practices
NAActive, not recruiting
115 participants
Started: Apr 25, 2023 · Completed: Mar 14, 2025
1 condition5 sponsors1 location
NCT05651516
Tau PET Imaging in Opioid Use Disorder
EARLY_PHASE1Recruiting
60 participants
Started: Apr 25, 2023 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT05739565
Impact of a Physical Activity Intervention With Motivational Support From Peers for Prostate Cancer Patients
NARecruiting
850 participants
Started: Apr 25, 2023 · Completed: Sep 30, 2026
1 condition6 sponsors25 locations
NCT05632601
Reexamining Her Cardiovascular Risk - Ottawa WomeN's Longitudinal Cohort Study
NARecruiting
210 participants
Started: Apr 25, 2023 · Completed: May 31, 2025
1 condition1 sponsor1 location
NCT05820477
FAMS-T1D Self-Regulation and Social Support for T1D
NAEnrolling by invitation
280 participants
Started: Apr 25, 2023 · Completed: Apr 30, 2027
1 condition5 sponsors2 locations
NCT05818033
Safety and Effectiveness of CARE1.02 Spectacle Lens in Myopia Control
NAActive, not recruiting
760 participants
Started: Apr 25, 2023 · Completed: Jun 30, 2025
1 condition1 sponsor1 location
NCT06480773
Kaposi Sarcoma Chemotherapy and Research (KS-CARE)
N/AActive, not recruiting
127 participants
Started: Apr 25, 2023 · Completed: Dec 31, 2026
2 conditions3 sponsors2 locations
NCT05864014
Hetrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Solid Tumors.
PHASE3Active, not recruiting
213 participants
Started: Apr 25, 2023 · Completed: Sep 30, 2025
1 condition1 sponsor1 location
NCT05612971
iAmHealthy Parents First: A Televideo Parent and Child Obesity Program for Rural Families
NARecruiting
480 participants
Started: Apr 25, 2023 · Completed: Dec 31, 2025
2 conditions3 sponsors1 location
NCT05732103
A Study of CTX-712 in Relapsed/Refractory Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes
PHASE1/PHASE2Recruiting
225 participants
Started: Apr 25, 2023 · Completed: Feb 28, 2029
2 conditions2 sponsors6 locations
NCT05689190
Non-invasive Flow Measurements in Patients with Lower Extremity Arterial Disease (LEAD)
N/ARecruiting
30 participants
Started: Apr 25, 2023 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05781087
Predicting the Risk of Non-culprit Coronary Artery Disease After a Heart Attack
N/ARecruiting
90 participants
Started: Apr 25, 2023 · Completed: Apr 30, 2028
3 conditions3 sponsors2 locations
NCT05728502
An Observational Study, Called VERI-China, to Learn More About How Well Vericiguat Works and How Safe it is in Real-world Setting in People With Chronic Heart Failure With Reduced Ejection Fraction (HFrEF) in China
N/ARecruiting
2,400 participants
Started: Apr 25, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05718817
An Open-label Study of XEN1101 in Epilepsy
PHASE3Enrolling by invitation
880 participants
Started: Apr 25, 2023 · Completed: Sep 30, 2028
2 conditions2 sponsors126 locations
NCT05795413
Quality of Recovery From Mastectomy With and Without PECS Blocks
N/AActive, not recruiting
800 participants
Started: Apr 25, 2023 · Completed: Apr 30, 2027
2 conditions1 sponsor1 location
NCT05554328
Testing the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial
PHASE2Recruiting
165 participants
Started: Apr 25, 2023 · Completed: Oct 1, 2028
4 conditions2 sponsors282 locations
NCT06346366
Glucose Control Through a Bihormonal Artificial Pancreas in Patients After Total Pancreatectomy
PHASE3Active, not recruiting
40 participants
Started: Apr 25, 2023 · Completed: Apr 1, 2024
3 conditions1 sponsor1 location
NCT05705973
Ultimaster Nagomi™ Sirolimus Eluting Coronary Stent System in Complex PCI Patients
N/AActive, not recruiting
3,000 participants
Started: Apr 25, 2023 · Completed: Apr 29, 2027
3 conditions1 sponsor52 locations
NCT05679544
Biological Signatures Resulting From Occupational Exposure to Complex Mixtures of PAHs
NARecruiting
100 participants
Started: Apr 25, 2023 · Completed: Oct 31, 2025
3 conditions1 sponsor1 location
NCT05870917
A Study of VRD-based Regimen Combined With CART-ASCT-CART2 Treatment in Patients With Primary Plasma Cell Leukemia
PHASE2Recruiting
20 participants
Started: Apr 25, 2023 · Completed: Apr 30, 2027
1 condition1 sponsor1 location
NCT05268237
Safety, Tolerability and Preliminary Efficacy of Sublingual Liraglutide in Patients With Type 2 Diabetes Mellitus
PHASE1/PHASE2Recruiting
15 participants
Started: Apr 25, 2023 · Completed: Mar 31, 2026
1 condition2 sponsors1 location
NCT05463796
InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer
N/ARecruiting
5,000 participants
Started: Apr 25, 2023 · Completed: Mar 25, 2032
31 conditions1 sponsor1 location
NCT07197658
Healing After Endodontic Microsurgery Using a Rotary Bur Versus Piezoelectric Unit for Osteotomy and Root Resection
NARecruiting
130 participants
Started: Apr 25, 2023 · Completed: Dec 10, 2026
3 conditions1 sponsor2 locations
NCT05878314
Impact of Endocrine Therapy, Menstrual Cycle, PAM50, Ki67 on Treatment Decisions in HR+ and HER2- Breast Cancer
N/ARecruiting
504 participants
Started: Apr 25, 2023 · Completed: Apr 30, 2035
1 condition3 sponsors1 location
NCT05788198
Integrated Depression Care
NARecruiting
150 participants
Started: Apr 25, 2023 · Completed: Sep 30, 2024
3 conditions3 sponsors2 locations
NCT05914285
Assessment of Salbutamol Effect on Arterial Oxygenation in COPD Patients During One-lung Ventilation
NAActive, not recruiting
90 participants
Started: Apr 25, 2023 · Completed: Jul 21, 2025
2 conditions1 sponsor1 location
NCT06957626
Development and Validation of Microbiota and Metabolite-based Prediction Model for Recurrence of High-risk Colorectal Polyps After Polypectomy
N/ARecruiting
150 participants
Started: Apr 25, 2023 · Completed: Apr 30, 2026
3 conditions1 sponsor1 location
NCT05991518
IAH0968 in Combination With GC for the Treatment of HER2-Positive Unresectable Advanced/Metastatic Malignant Tumors
PHASE1/PHASE2Recruiting
136 participants
Started: Apr 25, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05876234
The Predictive Value of Progesterone
N/AActive, not recruiting
3,000 participants
Started: Apr 25, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05500963
Reducing Fatigue in People With Multiple Sclerosis by Treatment With TENS
NARecruiting
60 participants
Started: Apr 25, 2023 · Completed: Nov 30, 2028
1 condition1 sponsor1 location
NCT05789953
PrEventing PostoPERative Pulmonary Complications by Establishing a MachINe-learning assisTed Approach
N/ARecruiting
512 participants
Started: Apr 25, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05103215
Lidocaine Infusion With ANI Monitoring in Spine Surgery.
PHASE4Recruiting
90 participants
Started: Apr 25, 2023 · Completed: Mar 31, 2025
1 condition1 sponsor1 location
NCT05732311
Intermittent Theta Burst Stimulation for Maintenance Therapy in Depression
NARecruiting
60 participants
Started: Apr 25, 2023 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05757102
A Study to Compare the Efficacy, Safety and Tolerability of FF/UMEC/VI With FF/VI in 12-17-year-olds With Asthma
PHASE3Recruiting
292 participants
Started: Apr 25, 2023 · Completed: Jan 15, 2027
1 condition1 sponsor42 locations
NCT05807061
Reducing Children's Racial Biases Via a Parent-Led Intervention
NAEnrolling by invitation
648 participants
Started: Apr 25, 2023 · Completed: Aug 31, 2026
1 condition2 sponsors1 location
NCT05677906
Rural Libraries Promoting Walking and Walkability in Their Rural Communities
PHASE1/PHASE2Active, not recruiting
331 participants
Started: Apr 25, 2023 · Completed: Dec 31, 2025
1 condition3 sponsors1 location
NCT05647733
Restrictive Fluid Management In Liver Transplantation (REFIL)
NARecruiting
72 participants
Started: Apr 25, 2023 · Completed: Jan 1, 2026
1 condition4 sponsors3 locations
NCT05994716
Telemonitoring for IBD Goodness Examination in Russia
NAEnrolling by invitation
62 participants
Started: Apr 25, 2023 · Completed: Oct 30, 2024
3 conditions2 sponsors1 location
NCT05619705
Healthy for Two-Home Visiting (H42-HV): Health Coaching for Pregnant Women
NARecruiting
360 participants
Started: Apr 25, 2023 · Completed: Jun 30, 2026
4 conditions2 sponsors1 location
NCT05564494
Surgical Treatment of Recurrent Shoulder Dislocations
NARecruiting
200 participants
Started: Apr 25, 2023 · Completed: Dec 31, 2027
1 condition2 sponsors1 location
NCT06141811
A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-302 Clinical Trial
N/ARecruiting
104 participants
Started: Apr 25, 2023 · Completed: Mar 31, 2026
1 condition1 sponsor4 locations
NCT05528926
RESist Against Irritability Superiority Trial
NARecruiting
270 participants
Started: Apr 25, 2023 · Completed: Sep 1, 2026
1 condition1 sponsor1 location
NCT05491031
MRI Biomarkers Predictive of Disability Progression in Patients With Multiple Sclerosis
NARecruiting
250 participants
Started: Apr 25, 2023 · Completed: May 1, 2028
2 conditions1 sponsor1 location
NCT06462716
A Phase l Study of By101298, an Oral DNA-PK Inhibitor, in Patients With Advanced Solid Tumors
PHASE1Active, not recruiting
36 participants
Started: Apr 25, 2023 · Completed: Jun 30, 2025
1 condition1 sponsor1 location